✦ LIBER ✦

Efficacy of reduced dose of IV topotecan (T) in relapsed small cell lung cancer (SCLC) patients

✍ Scribed by Fields, S.Z; Eckardt, J.R; Zhang, L; Poulin, R.K; Rose, G; Schiller, J.H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late phase II trials of topotecan (T) fo

✍ Y. Nishiwaki; S. Negoro; K. Watanabe; M. Fukuoka; H. Niitani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II study of topotecan (TOP) for re

✍ Ogawara, M; Negoro, S; Nishiwaki, Y; Fukuoka, M; Watanabe, K; Niitani, H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Topotecan in the Treatment of Elderly Pa

✍ Jennifer Garst; Richard Buller; Stephen Lane; Jeffrey Crawford 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 180 KB

126 Evaluation of topotecan (Hycamtin™)

✍ Depierre, A.; von Pawel, J.; Hans, K.; Moro, D.; Clark, P.; Gatzemeier, U.; Pail 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Systematic Review of topotecan (Hycamtin

✍ Rob Riemsma; Jean P Simons; Zahid Bashir; Caroline L Gooch; Jos Kleijnen 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 483 KB

A Phase II Study of Higher Dose Weekly T

✍ David R. Spigel; F. Anthony Greco; Howard A. Burris III; Dianna L. Shipley; Bobb 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 318 KB